828 | TRIAL IN PROGRESS: PEMBROLIZUMAB IN COMBINATION WITH SALVAGE CHEMOTHERAPY FOR FIRST‐RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (PEMBRO‐CORE). - Tharmaseelan, H.; Gillessen, S.; Bühnen, I.; Kaul, H.; Kobe, C.; Schrenk, K. G.; Topp, M. S.; Ernst, P.; Schnetzke, U.; Freund, N.; Sasse, S.; Zamrik, T.; et al. (Hematological oncology, 2025)